Daptomycin Therapy
Study results from O. Burkhardt and colleagues broaden understanding of daptomycin therapy
Published in Anti-Infectives Week, March 1st, 2010
"In that population, acute infections substantially contribute to the excessive morbidity and mortality. The risk for invasive methicillin-resistant Staphylococcus aureus infections in this population is approximately 100-fold higher than in the general population, therefore dialysis patients currently account for up to approximately 15% of all invasive methicillin-resistant Staphylococcus aureus infections," wrote O. Burkhardt and colleagues.
The researchers concluded: "A simplified three-times weekly dosing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
Source: Anti-Infectives Week (2010-03-01)
More Articles from Anti-Infectives Week
- Angiotensins
Studies in the area of angiotensins reported from Sankyo Co., Ltd. - Antimicrobials
New antimicrobials study findings recently were published by researchers at University of New South Wales - Atopic Dermatitis
Data on atopic dermatitis described by researchers at University of Minnesota - Drug Resistance
New drug resistance study findings have been reported by M.A. Argudin and co-researchers - Drug Resistance
Scientists at University of British Columbia target drug resistance - Drug Resistance
Studies from Hirosaki University yield new data on drug resistance - More from this issue of Anti-Infectives Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
